| Literature DB >> 35387685 |
Matthew C Peters1, Alexander Murray-Douglass1, Joseph Park1, Sean S H Cheng1, Anil K Sharma1, Abhishek Sharma1, Kevin W Vandeleur1, Lawrence R Lee1, Thomas P Moloney2.
Abstract
BACKGROUND: To determine patient and surgical factors associated with the use of 360-degree laser retinopexy during primary pars plana vitrectomy (PPV) ± scleral buckle (SB) for rhegmatogenous retinal detachment (RRD) and its impact on surgical outcomes.Entities:
Keywords: 360 Laser retinopexy; Retinal detachment; Retinopexy
Year: 2022 PMID: 35387685 PMCID: PMC8985359 DOI: 10.1186/s40942-022-00377-1
Source DB: PubMed Journal: Int J Retina Vitreous ISSN: 2056-9920
Baseline characteristics of patients undergoing PPV or combined PPV with SB
| 360 Laser (n = 130) | Limited laser (n = 62) | ||
|---|---|---|---|
| Age, mean (SD), years | 63.2 ± 13.0 | 64.6 ± 12.3 | 0.087 |
| Female, n (%) | 31 (23.8%) | 25 (40.3%) | 0.069 |
| Right eye | 63 (48.5%) | 33 (53.2%) | 0.317 |
| Preoperative logMAR visual acuity | 1.6 ± 1.2 (~ 6/240) | 1.1 ± 1.0 (~ 6/75) | 0.017 |
| Lens status | |||
| Phakic (base variable) | 77 (59.2%) | 38 (61.3%) | |
| Pseudophakic | 52 (40%) | 23 (37.1%) | 0.559 |
| Aphakic | 1 (0.8%) | 1 (1.6%) | 0.711 |
| Macula status | |||
| On (base variable) | 36 (27.7%) | 26 (41.9%) | |
| Off | 91 (70.0%) | 31 (50.0%) | 0.763 |
| Split/threatened | 3 (2.3%) | 5 (8.1%) | 0.086 |
| PVR grade | |||
| Nil (base variable) | 90 (69.2%) | 50 (80.6%) | |
| A | 3 (2.3%) | 10 (16.1%) | 0.013 |
| B | 18 (13.8%) | 1 (1.6%) | 0.022 |
| CP1-3 | 9 (6.9%) | 1 (1.6%) | 0.377* |
| CP4-6 | 6 (4.6%) | 0 (0.0%) | |
| CP7-9 | 2 (1.5%) | 0 (0.0%) | |
| CP10-12 | 2 (1.5%) | 0 (0.0%) |
For statistical analysis, CP1-3, CP4-6, CP7-9 and CP10-12 were combined as ‘CP1-12’
Multivariate regression analysis of the use of 360-degree laser retinopexy
| Odds ratio | 95% CI | ||
|---|---|---|---|
| Preoperative logMAR visual acuity | 1.487 | 1.105 to 2.002 | 0.009 |
| Female | 1.981 | 0.971 to 4.042 | 0.060 |
| PVR grade (base variable nil) | |||
| A | 0.150 | 0.038 to 0.602 | 0.007 |
| B | 9.670 | 1.238 to 75.522 | 0.030 |
| CP1-12 | 7.429 | 0.943 to 58.494 | 0.057 |
Surgical decisions associated with the use of 360-degree laser retinopexy
| 360 Laser (n = 130) | Limited laser (n = 62) | ||
|---|---|---|---|
| Surgical technique | |||
| PPV | 94 (72.3%) | 53 (85.5%) | 0.0468 |
| PPV with SB | 36 (27.7%) | 9 (14.5%) | |
| Tamponade agent | |||
| SF6 | 15 (11.5%) | 30 (48.4%) | < 0.0001 |
| C3F8 | 65 (50.0%) | 25 (40.3%) | |
| Silicone oil | 50 (38.5%) | 6 (9.7%) |
Primary and secondary outcomes of patients undergoing PPV or combined PPV with SB
| 360 Laser (n = 130) | Limited laser (n = 62) | ||
|---|---|---|---|
| Single surgery anatomical success | 112 (86.2%) | 47 (75.8%) | 0.079 |
| Final logMAR visual acuity | 0.9 ± 0.9 (~ 6/48) | 0.6 ± 0.8 (~ 6/24) | 0.0623 |
| ERM development | 17 (13.1%) | 9 (14.5%) | 0.8208 |
| Postoperative CMO | 11 (8.5%) | 7 (11.3%) | 0.5946 |
| Tonic pupil | 3 (2.3%) | 1 (1.6%) | > 0.9999 |
| Corneal epithelial defect | 1 (0.8%) | 0 (0.0%) | N/A |